Pamuk Bilsel
Principal investigator, leads FLUGEN, INC..
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$3.8MFederal grants as PI6 awards
3Patents grantedLatest May 14, 2024
35Papers834 citations
Federal awards and patents by year
AwardsPatents
6 awards · $3.8M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Nov 13, 2018 | NIH | SBIR Phase II Development of a novel highly effective influenza vaccine | $656K | FLUGEN, INC. |
| Jul 18, 2018 | NIH | STTR Phase II Restimulating memory T cell responses in elderly by a novel, live influenza vaccine | $1.1M | FLUGEN, INC. |
| Dec 20, 2017 | NIH | SBIR Phase II Development of a novel highly effective influenza vaccine | $834K | FLUGEN, INC. |
| Jun 24, 2017 | NIH | STTR Phase II Restimulating memory T cell responses in elderly by a novel, live influenza vaccine | $746K | FLUGEN, INC. |
| Jul 28, 2015 | NIH | STTR Phase I Restimulating memory T cell responses in elderly by a novel, live influenza vaccine | $225K | FLUGEN, INC. |
| May 6, 2015 | NIH | STTR Phase I Development of a novel highly effective influenza vaccine | $300K | FLUGEN, INC. |
4 patents as inventor
- US 11040098FLUGEN, INC.Jun 22, 2021
- US 11207399FLUGEN, INC.Dec 28, 2021
- US 11980661FLUGEN, INC.May 14, 2024
- US FLUGEN, INC.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#422
Awards as PI#315
Patents#63
Companies
- FLUGEN, INC.Leads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.